Article
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
European urology - 1 Dec 2018
Qu Le, Wang Ze-Lin, Chen Qi, Li Yao-Ming, He Hao-Wei, Hsieh James J, Xue Song, Wu Zhen-Jie, Liu Bing, Tang Hao, Xu Xiao-Feng, Xu Feng, Wang Jie, Bao Yi, Wang An-Bang, Wang Dong, Yi Xiao-Ming, Zhou Zhong-Kui, Shi Chang-Jie, Zhong Ke, Sheng Zheng-Cheng, Zhou Yu-Lin, Jiang Jun, Chu Xiao-Yuan, He Jia, Ge Jing-Ping, Zhang Zheng-Yu, Zhou Wen-Quan, Chen Cheng, Yang Jian-Hua, Sun Ying-Hao, Wang Lin-Hui
Abstract excerpt
BACKGROUND: Long non-coding RNAs (lncRNAs) can be used as prognostic biomarkers in many types of cancer. OBJECTIVE: We sought to establish an lncRNA signature to improve postoperative risk stratification for patients with localized clear cell renal cell carcinoma (ccRCC). DESIGN, SETTING, AND PARTICIPANTS: Based on the RNA-seq data of 444 stage I-III ccRCC tumours from The Cancer Genome Atlas project, we built a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
